![Transparency Market Researchが調査・発行した産業分析レポートです。アメリカのドライアイ診断装置市場2021年ｰ2031年：装置種類別（前眼部OCT （AS-OCT）、マイボグラフィー装置、角膜トポグラファー、浸透圧検査装置、眼表面サーモグラファー、干渉計、蛍光光度計、その他）、疾患別、エンドユーザー別 / Dry Eye Disease Diagnostic Devices Market (Device Type: Anterior Segment OCT [AS-OCT], Meibography Device, Corneal Topographer, Osmolarity Testing Device, Ocular Surface Thermographer, Interferometer, Fluorophotometer, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome: and End-user: Hospitals, Diagnostic Centers, Ophthalmology Centers/Clinic, and Others) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 / MRC2204A217資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-53.gif) | • レポートコード：MRC2204A217 • 出版社/出版日：Transparency Market Research / 2022年1月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、アメリカのドライアイ診断装置市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、装置種類別分析、疾患別分析、エンドユーザー別分析、競争状況などを掲載しています。 |
U.S. Dry Eye Disease Diagnostic Devices Market – Scope of ReportTMR’s report on the dry eye disease diagnostic devices market in the U.S. studies the current as well as future prospects of the dry eye disease diagnostic devices market in the U.S. Stakeholders of the report include companies and intermediaries engaged in dry eye disease diagnostic devices as well as new players planning to enter the market.
The report provides market value in terms of US$ Mn for the period from 2017 to 2031, along with the compound annual growth rate (CAGR %) from 2021 to 2031 for all segments, considering 2020 as the base year and 2017–2019 as the historical years.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dry eye disease diagnostic devices market in the U.S.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the dry eye disease diagnostic devices market in the U.S.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the dry eye disease diagnostic devices market in the U.S. with respect to the leading market segments based on device type, disease, and end-user.
The dry eye disease diagnostic devices market in the U.S. has been studied based on major segments.
The report delves into the competition landscape of the dry eye disease diagnostic devices market in the U.S. Key players operating in the market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the dry eye disease diagnostic devices market in the U.S. profiled in this report.
Key Questions Answered in U.S. Dry Eye Disease Diagnostic Devices Market Report
What is the sales/revenue generated by dry eye disease diagnostic device suppliers/manufacturers across the U.S. during the forecast period?
What are the key trends in the dry eye disease diagnostic devices market in the U.S.?
What are the major drivers, restraints, and opportunities in the market?
Which segment will have the highest revenue in 2031 and which segment will grow at the highest CAGR during the forecast period?
U.S. Dry Eye Disease Diagnostic Devices Market – Research Objectives and Research Approach
The comprehensive report on the dry eye disease diagnostic devices market in the U.S. begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market share of key segments in the past and at the end of the forecast period.
The report analyzes the dry eye disease diagnostic devices market in the U.S. in terms of device type, disease, and end-user. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the dry eye disease diagnostic devices market in the U.S.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Dry Eye Disease Diagnostic Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S. Dry Eye Disease Diagnostic Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Number of facilities for end-user types
5.2. Technological Advancements
5.3. Epidemiology of Dry Eye Disease in the U.S.
5.4. Pricing Analysis
5.5. Key Mergers & Acquisitions
5.6. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. U.S. Dry Eye Disease Diagnostic Devices Market Analysis and Forecast, by Device Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Device Type, 2017–2031
6.3.1. Anterior Segment OCT (AS-OCT)
6.3.2. Ocular Surface Thermographer
6.3.3. Corneal Topographer
6.3.4. Osmolarity Testing Device
6.3.5. Fluorophotometer
6.3.6. Interferometer
6.3.7. Meibography Device
6.3.8. Others
6.4. Market Attractiveness Analysis, by Device Type
7. U.S. Dry Eye Disease Diagnostic Devices Market Analysis and Forecast, by Disease
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease, 2017–2031
7.3.1. Evaporative Dry Eye Syndrome
7.3.2. Aqueous Dry Eye Syndrome
7.4. Market Attractiveness Analysis, by Disease
8. U.S. Dry Eye Disease Diagnostic Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Materials by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Ophthalmology Centers/Clinic
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Competition Landscape
9.1. Company Profiles
9.1.1. Johnson & Johnson Services, Inc.
9.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.1.2. Product Portfolio
9.1.1.3. SWOT Analysis
9.1.1.4. Strategic Overview
9.1.2. OCULUS Optikgeräte GmbH
9.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.2.2. Product Portfolio
9.1.2.3. SWOT Analysis
9.1.2.4. Strategic Overview
9.1.3. Carl Zeiss Meditec AG
9.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.3.2. Product Portfolio
9.1.3.3. SWOT Analysis
9.1.3.4. Strategic Overview
9.1.4. TearLab Corporation
9.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.4.2. Product Portfolio
9.1.4.3. SWOT Analysis
9.1.4.4. Strategic Overview
9.1.5. Optovue, Inc.
9.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.5.2. Product Portfolio
9.1.5.3. SWOT Analysis
9.1.5.4. Strategic Overview
9.1.6. AXIM Biotechnologies
9.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.6.2. Product Portfolio
9.1.6.3. SWOT Analysis
9.1.6.4. Strategic Overview
9.1.7. Topcon Corporation
9.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.7.2. Product Portfolio
9.1.7.3. SWOT Analysis
9.1.7.4. Strategic Overview
9.1.8. Quantel Medical
9.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.8.2. Product Portfolio
9.1.8.3. SWOT Analysis
9.1.8.4. Strategic Overview
9.1.9. Essilor Instruments
9.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.9.2. Product Portfolio
9.1.9.3. SWOT Analysis
9.1.9.4. Strategic Overview
9.1.10. I-MED Pharma inc.
9.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.10.2. Product Portfolio
9.1.10.3. SWOT Analysis
9.1.10.4. Strategic Overview
9.1.11. Box Medical Solutions Inc.
9.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.11.2. Product Portfolio
9.1.11.3. SWOT Analysis
9.1.11.4. Strategic Overview
9.1.12. NIDEK CO., LTD.
9.1.12.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.12.2. Product Portfolio
9.1.12.3. SWOT Analysis
9.1.12.4. Strategic Overview
Table 01: Number of facilities for end-user types (2020)
Table 02: Pricing Analysis
Table 03: Key Development – Acquisitions & Mergers
Table 04: U.S. Dry Eye Disease Diagnostic Devices Market Value (US$ Mn) Forecast, by Device Type, 2017–2031
Table 05: U.S. Dry Eye Disease Diagnostic Devices Market Value (US$ Mn) Forecast, by Disease, 2017–2031
Table 06: U.S. Dry Eye Disease Diagnostic Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031